Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (171-180 of 355) with videos related to

Pageof 36
Sort By:
Journal of Translational Medicine|August 11, 2011
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytesQunrui Ye, Maria Loisiou, Bruce L Levine, et al.
Plos Computational Biology|August 24, 2017
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificityMichal Bassani-Sternberg, Chloé Chong, Philippe Guillaume, et al.
Molecular Imaging and Biology|February 6, 2009
In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomesNatalie A Christian, Fabian Benencia, Michael C Milone, et al.
Molecular & Cellular Proteomics : MCP|September 2, 2018
Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I LigandomeRoman Mylonas, Ilan Beer, Christian Iseli, et al.
Journal of Translational Medicine|May 26, 2011
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyIoannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas, et al.
Nature Cell Biology|October 6, 2009
KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancerKiranmai Gumireddy, Anping Li, Phyllis A Gimotty, et al.
Journal of Translational Medicine|January 10, 2008
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancerDavid O Holtz, Robert T Krafty, Alisha Mohamed-Hadley, et al.
Scientific Reports|January 22, 2022
A cell-based phenotypic library selection and screening approach for the de novo discovery of novel functional chimeric antigen receptorsJulie K Fierle, Johan Abram-Saliba, Vasileios Atsaves, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2018
The C-terminal extension landscape of naturally presented HLA-I ligandsPhilippe Guillaume, Sarah Picaud, Petra Baumgaertner, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2024
Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion AnalysisYen-Cheng Liu, Saeid Ansaryan, Jiayi Tan, et al.
Pageof 36

Showing results (171-180 of 355) with videos related to

Sort By:
Pageof 36
Journal of Translational Medicine|August 11, 2011
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytesQunrui Ye, Maria Loisiou, Bruce L Levine, et al.
Plos Computational Biology|August 24, 2017
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificityMichal Bassani-Sternberg, Chloé Chong, Philippe Guillaume, et al.
Molecular Imaging and Biology|February 6, 2009
In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomesNatalie A Christian, Fabian Benencia, Michael C Milone, et al.
Molecular & Cellular Proteomics : MCP|September 2, 2018
Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I LigandomeRoman Mylonas, Ilan Beer, Christian Iseli, et al.
Journal of Translational Medicine|May 26, 2011
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyIoannis Alagkiozidis, Andrea Facciabene, Marinos Tsiatas, et al.
Nature Cell Biology|October 6, 2009
KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancerKiranmai Gumireddy, Anping Li, Phyllis A Gimotty, et al.
Journal of Translational Medicine|January 10, 2008
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancerDavid O Holtz, Robert T Krafty, Alisha Mohamed-Hadley, et al.
Scientific Reports|January 22, 2022
A cell-based phenotypic library selection and screening approach for the de novo discovery of novel functional chimeric antigen receptorsJulie K Fierle, Johan Abram-Saliba, Vasileios Atsaves, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2018
The C-terminal extension landscape of naturally presented HLA-I ligandsPhilippe Guillaume, Sarah Picaud, Petra Baumgaertner, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2024
Nanoplasmonic Single-Tumoroid Microarray for Real-Time Secretion AnalysisYen-Cheng Liu, Saeid Ansaryan, Jiayi Tan, et al.
Pageof 36